Sensus Healthcare Inc.
SRTS | NASDAQ
$3.08
+$0.01 (+0.33%)
Sep 22, 2026, 11:33 AM ET · Market open
Company Profile
Sensus Healthcare, Inc. operates as a medical technology enterprise, manufacturing and distributing radiation therapy apparatuses to medical institutions across the globe. The company's portfolio leverages superficial radiation therapy (SRT), a cutting-edge low-energy X-ray methodology. Their product line features the SRT-100, a photon X-ray system for low-energy superficial radiotherapy. This device presents a non-surgical alternative for patients dealing with non-melanoma skin cancers, including basal cell and squamous cell carcinomas, alongside other dermatological issues like keloids. Another key offering is the SRT-100 Vision, which incorporates a specialized SRT treatment planning application. This application seamlessly integrates an embedded high-frequency ultrasound imaging module, tools for volumetric tumor analysis, beam margin delineation, and dosimetry parameter configuration. In addition, Sensus Healthcare provides the SRT-100 Plus, the Sentinel service program to ensure system protection for its clients, and options for in-office laser rentals. They also supply various consumable items, such as replacement lead shielding, disposable radiation safety gear like aprons and eye shields, ultrasound probe film, and single-use applicator tips designed to treat lesions of different sizes and on various body areas. Founded in 2010, Sensus Healthcare, Inc. maintains its corporate headquarters in Boca Raton, Florida.
Key Executives
| Name | Position |
|---|---|
| Joseph C. Sardano | Co-Founder, Chairman & Chief Executive Officer |
| Carlton Chow | Chief Technology Officer |
| Javier Rampolla | Chief Financial Officer |
| Magdalena Martinez | Chief Operating Officer |
| Michael J. Sardano | President, Chief Commercial Officer, General Counsel, Corporate Secretary & Director |
| Stephanie Tipton | Vice President of Marketing |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 31, 2026 | 4 | Filing |
| Aug 28, 2026 | 4 | Filing |
| Aug 25, 2026 | 4 | Filing |
| Aug 24, 2026 | 4 | Filing |
| Aug 24, 2026 | 4 | Filing |
| Aug 14, 2026 | 10-Q | Quarterly Report |
| Aug 13, 2026 | 8-K | Current Report |
| Jun 05, 2026 | 8-K | Current Report |
| Jun 02, 2026 | 8-K | Current Report |
| May 18, 2026 | SD | Filing |
Sensus Healthcare Inc.
| Country | United States |
| IPO Date | Jul 25, 2016 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 60 |
| CEO | Joseph C. Sardano |
Contact Details
851 Broken Sound Parkway NW Boca Raton,
Florida 33487 United States
Stock Details
| Ticker Symbol | SRTS |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001494891 |
| CUSIP Number | 81728J109 |
| ISIN Number | US81728J1097 |
| SIC Code | 3841 |
Add to Watchlist
Select watchlists to add or remove SRTS